BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7678696)

  • 1. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
    Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
    Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
    Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
    Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
    Dick FA; Sailhamer E; Dyson NJ
    Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
    Patrick DR; Oliff A; Heimbrook DC
    J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
    Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE
    J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
    Wu EW; Clemens KE; Heck DV; Münger K
    J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
    Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
    Arroyo M; Bagchi S; Raychaudhuri P
    Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR; Harlow E; Helin K
    Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.
    Melillo RM; Helin K; Lowy DR; Schiller JT
    Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
    Zerfass K; Levy LM; Cremonesi C; Ciccolini F; Jansen-Dürr P; Crawford L; Ralston R; Tommasino M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
    Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
    Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.
    Hwang SG; Lee D; Kim J; Seo T; Choe J
    J Biol Chem; 2002 Jan; 277(4):2923-30. PubMed ID: 11713253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma protein reverses DNA bending by transcription factor E2F.
    Huber HE; Goodhart PJ; Huang PS
    J Biol Chem; 1994 Mar; 269(9):6999-7005. PubMed ID: 8120063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
    Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.
    Hiraiwa A; Kiyono T; Suzuki S; Ohashi M; Ishibashi M
    Virus Genes; 1996; 12(1):27-35. PubMed ID: 8879118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
    Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.